Albumin in Acute Ischemic Stroke Trial (ALIAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00235495
Recruitment Status : Terminated (Recruitment halted by DSMB following interim analysis.)
First Posted : October 10, 2005
Last Update Posted : November 15, 2012
National Institute of Neurological Disorders and Stroke (NINDS)
University of Calgary
Medical University of South Carolina
Neurological Emergencies Treatment Trials Network (NETT)
Information provided by (Responsible Party):
Myron Ginsberg, University of Miami

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Terminated
  Estimated Primary Completion Date : February 2013
  Estimated Study Completion Date : June 2014

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 December 12, 2017
January 11, 2018
Publications automatically indexed to this study by Identifier (NCT Number):